Geert Cauwenbergh
2013
In 2013, Geert Cauwenbergh earned a total compensation of $1.1M as President and Chief Executive Officer at RXi Pharmaceuticals, a 57% decrease compared to previous year.
Compensation breakdown
Bonus | $187,500 |
---|---|
Option Awards | $538,669 |
Salary | $368,135 |
Other | $956 |
Total | $1,095,260 |
Cauwenbergh received $538.7K in option awards, accounting for 49% of the total pay in 2013.
Cauwenbergh also received $187.5K in bonus, $368.1K in salary and $956 in other compensation.
Rankings
In 2013, Geert Cauwenbergh's compensation ranked 6,201st out of 12,286 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 49.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,201 out of 12,286 | 50th |
Division Manufacturing | 2,164 out of 4,612 | 53rd |
Major group Chemicals And Allied Products | 640 out of 1,462 | 56th |
Industry group Drugs | 462 out of 1,156 | 60th |
Industry Pharmaceutical Preparations | 370 out of 890 | 58th |
Source: SEC filing on April 16, 2015.
Cauwenbergh's colleagues
We found one more compensation record of an executive who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2013.
2013
Pamela Pavco
RXi Pharmaceuticals